PRO155 COST–UTILITY ANALYSIS OF RAVULIZUMAB COMPARED WITH ECULIZUMAB IN GERMAN ADULT OUTPATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Abstract
Authors
T. OConnell M.G. Buessing L. Tu I. Tomazos S.K. Thomas K.J. Myren
T. OConnell M.G. Buessing L. Tu I. Tomazos S.K. Thomas K.J. Myren
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now